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What's already known about this topic? 
• The prevalence of psoriasis in children is lower than adults 
• A significant number of adults with psoriasis first developed skin disease in childhood 
• Genetic and environmental factors both play an important role in the onset of 
psoriasis 
• Disease associations, such as obesity, are an important area of current research 
activity 
 
What does this study add? 
• Mapping has shown a dramatic increase in the number of published studies over the 
past 25 years 
• Studies have been concentrated in Europe, Asia and North America; these studies 
have largely been case series or cross-sectional studies 
• Specific studies with standardised methodologies are needed to provide data on the 
frequency, clinical presentation, risk factors, associated diseases and long-term 
outcomes for child-onset psoriasis 
 
 
 
 
 
The Epidemiology of Childhood Psoriasis: A Scoping Review 
 
Abstract 
Psoriasis is an inflammatory non-communicable skin disease which affects both adults and 
children. At present the epidemiology and natural history of psoriasis are not widely 
understood. This scoping review aimed to map the existing literature on the epidemiology 
of child-onset psoriasis, provide a comprehensive, clinically useful review and identify 
research gaps for future studies. 
 
Search strategies were developed for OVID MEDLINE, OVID Embase, Google Scholar and 
hand-searching; 131 articles meeting the inclusion criteria and were mapped and 107 
articles were included for data extraction.  
 
Over 25 years there has been a dramatic increase in the volume of published observational 
epidemiological studies on child-onset psoriasis. The majority were case series or cross-
sectional studies, concentrated in Europe, Asia and North America. The prevalence of 
childhood psoriasis was found to be higher in European countries, older children and 
females. Up to 48.8% of children had psoriasis in a first degree relative. The most frequent 
subtype was plaque psoriasis and initial site of presentation is most commonly scalp, limbs 
and trunk. Specific genetic differences have been found between the child-onset and adult-
onset populations. Case-control studies and cohort studies investigating risk factors for 
psoriasis onset, comorbidities and long-term health outcomes were extremely limited.  
 
The choice of study design and heterogeneity in methodology limit the validity and 
generalisability on the information, consistency of the results and comparability of the 
studies. Well-designed studies are needed to provide precise and consistent information 
about the frequency and clinical presentation, risk factors, associated diseases and long-
term outcomes in child-onset psoriasis. 
 
 
Introduction 
 
Psoriasis is an inflammatory non-communicable skin disease which affects both adults and 
children 1. Early onset disease may persist into adulthood. Lomholt examined a little over 
one-third of the population of the Faroe Islands and found that over 70% of those diagnosed 
with psoriasis had an age of onset before 20 years 2. In Sweden 50% of the 5197 families 
surveyed by Swanbeck et al developed psoriasis before the age of 25 years 3. In view of the 
likely common occurrence and chronic nature of child-onset psoriasis it is important that 
best practice management is initiated early and information is readily available for children 
and their families.  
 
At present the epidemiology and natural history of psoriasis are not widely understood. 
Instead recent scientific activity on psoriasis has focused on disease pathophysiology 4,5, 
driven by the development of targeted biological therapies, and the role that systemic 
inflammation may play in psoriasis morbidity and mortality 6,7 . Epidemiological studies not 
only contribute to understanding distribution and determinants of disease, but also inform 
primary and secondary prevention measures, including therapeutic interventions 8. 
Additionally, they can help answer questions important to patients and health providers 
about how common, possible causes and long-term outcomes of the condition. 
 
Scoping reviews aim to map the existing literature in a field of interest in terms of the 
volume, nature and characteristics of the primary research 9. This scoping review also aimed 
to provide a comprehensive, clinically useful review of the epidemiology of child-onset 
psoriasis and identify research gaps for future studies. The four core questions addressed by 
this review were: 
 
1. What are the prevalence, incidence and clinical presentation of childhood psoriasis? 
2. What are the genetic and environmental factors associated with the onset of 
psoriasis in childhood? 
3. What other conditions are associated with psoriasis in children? 
4. What are the long-term outcomes for patients with child-onset psoriasis? 
 
 
Method 
 
The search strategy was designed with an information specialist (DG) (Appendix 1). OVID 
MEDLINE In-Process & Non-Indexed Citations and OVID MEDLINE 1948 to present, and OVID 
Embase were searched on 27th May 2015. The reference lists of 10% of studies included in 
the review and non-systematic review articles were hand searched to identify additional 
relevant studies. Google Scholar was searched using the terms ‘epidemiology of psoriasis in 
children’ and ‘epidemiology of paediatric psoriasis’ and the first 100 citations were reviewed 
on 15th September 2015. 
 
Studies were included if they were observational studies of children with psoriasis, or 
studies with separated data for children, that provided primary epidemiological data on one 
of the four core questions. Children were defined as those with a disease onset under the 
age of 18 years; although flexibility was shown for studies with grouped data up to the age 
of 20 years. Systematic reviews of observational studies were included. Therapeutic 
intervention studies and single case reports were excluded. Non-English studies and 
conference abstracts were included as part of mapping the extent of the evidence, but 
results data were not extracted. 
 
Titles, abstracts and full-text articles where available were screened by two authors (EBT 
and EA). The full-texts of studies which met the inclusion criteria were then independently 
assessed for eligibility by two authors (EBT and RM). Data extraction was undertaken by one 
author (EBT) using a structured form. The accuracy of the extracted data for 10% of included 
studies was checked by a second author (RM). Studies were categorised for mapping of the 
literature according to definitions provided in the publication and descriptions provided in 
the methods section.  
 
The breadth of the review questions and the heterogeneity of the studies have necessitated 
narrative synthesis of the data. Critical appraisal of individual studies and meta-analysis was 
not performed within this scoping review. 
 
Results 
 
The search strategy yielded 2490 potential citations; after removal of duplicates, initial 
screening and review for eligibility 113 articles remained. A further 19 articles were 
identified through hand-searching and Google Scholar. In total 131 articles were mapped, 
after removal of non-English studies and conference abstracts, 107 articles were included in 
the results summary (Appendix 2). 
 
Mapping of studies 
The characteristics of included studies are presented in Table 1. There has been a linear 
increase in the number of observational studies on child-onset psoriasis over the past 20 
years (1996-2000 n=8, 2011-2015 n=50). The majority of the study populations were based 
in Europe (65/131), in particular UK (10/131), Sweden (9/131), Germany (7/131) and Turkey 
(6/131).  
 
Cross-sectional studies (75/131) and case series (30/131) were most common. 
Observational studies to date have concentrated on incidence or prevalence (47/131), age 
of onset, gender or family history (69/131) and clinical presentation of psoriasis (63/131)..  
 
What are the prevalence, incidence and clinical presentation of childhood psoriasis? 
 
Incidence and prevalence  
Overall there were two incidence, 37 prevalence studies and one systematic review 10. 
Seventeen prevalence studies were population- based 11-27. Twenty studies were 
secondary/hospital care prevalence studies 28-47. 
 
The prevalence of childhood psoriasis varied depending on the study population. Estimates 
reported from population-based studies range from 0% to 2.1%, the highest values were 
from European studies, Italy (2.1%  21), Germany (1.3% 12) and UK (1.3% for 10-19 year old 
17) compared to low prevalence in Taiwan (0% 15,27) and Egypt (0.05% 26). Studies which 
stratified prevalence according to age reported psoriasis to be more common after puberty, 
0.6% to 1.3%, than before puberty, 0.1% to 0.5%. Psoriasis was a fairly common 
presentation in paediatric dermatology clinics with a reported prevalence of 0.7% to 6.2% of 
outpatient consultations 
 
With regard to incidence studies, a health survey of Norwegian twins showed that incidence 
of psoriasis increased with age throughout childhood (0-3 years to 16-19 years) from 0.5 to 
2.9 and 0.3 to 2.0 per 1000 person years in girls and boys respectively 48. Tollefson et al 
showed that the number of children diagnosed with psoriasis had increased over a 30 years 
period in the United States from 29.6 to 62.7 per 100 000 patient years. Proposed reasons 
for this increase included changes in risk factors such as psychosocial stress, infection and 
obesity 49. 
 
Studies varied in how cases of psoriasis were ascertained (self-reported, diagnostic codes in 
health records, physician examination) and potentially how psoriasis was defined; most 
studies required a ‘clinical diagnosis’ of psoriasis with no pre-defined criteria.  
 
Gender and age of onset 
Forty-two studies provided data on the gender distribution. Thirty-three studies provided 
data on the percentage of the study population which were male 25,28,30,32,50-78. Twenty five 
of these 33 studies found that less than 50% of children with psoriasis were boys (range 
35.9-49%).The male to female ratio was provided in 16 studies and varied from 1.14:1 to 
1:2.33 30,32,34,49,52,59,60,70,72,75,79-84. Matusiewicz et al reported that the prevalence of psoriasis 
in children was lower in boys than girls, 0.35% compared to 0.44% 20, and Farber et al’s 
survey of 5600 psoriasis patients found that in childhood onset in boys was less common 
than girls especially amongst those with an onset under the age of 10 years 73. This female 
predominance seen in the prevalence of childhood psoriasis is the opposite of what is 
commonly observed in adults 85. 
 
Age at onset of psoriasis was reported by 30 studies. The range of age at onset was reported 
by 17 studies and range included from birth to 18 years 30,32,52,53,55,57-59,63,67,72,74,79,83,86-88. The 
average age of onset was reported by 22 studies and ranged from 2.1 months to 10.6 years 
28,32,34,49-53,55,58,60,65,69,71,72,74,77,79,80,82,83,89. 
 
Age of onset may vary with psoriasis subtype. An earlier age of onset was reported for 
pustular psoriasis 53,83. Popadic et al described the 20 year experience of childhood pustular 
psoriasis at their centre and found 50% of children presented before 1 year old 83. The 
average age of onset in plaque psoriasis is less clear. This variation may reflect differences in 
subtype definition, for example, inclusion of scalp, flexural or napkin psoriasis in the term 
plaque psoriasis. Leow et al reported a case series of 112 children; 91.9% had plaque 
psoriasis and 37.5% developed psoriasis under 1 year old 34. However, four studies with 
predominantly plaque psoriasis reported an average age of onset around 10 years 41,58,60,80. 
Only one study contained children predominantly with guttate psoriasis and found a clear 
peak in age of onset for girls at eight years but possibly three peaks for boys at 5, 10 and 13 
years 77. 
 
Reliance on medical documentation and patient/parent recall as well as inconsistencies in 
subtype definition all contribute to difficulties in accurately understanding age of onset in 
childhood psoriasis. 
 
Family history 
Thirty-eight studies provided data on family history 28,30,32,34,50-65,67,69,70,72,76-84,86,87,89-91. The 
percentages of children with a positive history in a first degree relative varied from 6.2% to 
54.7% and a positive family history in any family member from 4.5% to 88%. Farber et al 
found that adolescents with psoriasis (10-19 years) were most likely to have a family 
member with psoriasis, compared to other age groups of children 86. The large variation 
reported in family history of psoriasis may in part be due to genetic differences between 
ethnic populations. For example, a study comparing Asian and European children found only 
13.6% of Singaporean children had a first or second degree relative affected by psoriasis 
compared with 73.3% of Dutch children 79. This supports child-onset psoriasis as a 
genetically heterogeneous condition and further research is needed into gene-environment 
interactions in different populations.  
 
 
Clinical presentation 
Eleven studies reported the initial body site of presentation in child-onset psoriasis 
30,34,55,58,59,69,72,76,80,82,84. Collectively they included nearly 3000 children. The scalp, limbs and 
trunk were the most common sites of initial presentation (17.9% to 64.8%, 9.5% to 90%, and 
7.8% to 93.3% respectively).  The face was a common site of presentation, 3.5% to 56.7%, 
and facial involvement may be an important clinical sign when differentiating psoriasis from 
eczema in children 28. Napkin psoriasis was present in most infants with psoriasis and 
therefore needs to be considered an important presenting sign in this age group 86. 
 
Twenty-three studies presented data on the frequency of different subtypes in childhood 
psoriasis in a 28,30,32,34,49,51,52,55,56,58-64,70,72,79,80,84,90,91 . As in the adult population, the 
commonest subtype in was chronic plaque. The range of frequencies of different subtypes 
was as follows: plaque psoriasis 9% to 91.9%, guttate psoriasis 1.6% to 48.2%, pustular 0% 
to 13.1%, erythrodermic 0.1% to 5.8%, palmoplantar 0.9% to 12.8%. Nail psoriasis was also a 
common subtype or current site of involvement, between 2% and 39.3%, and one study 
found it to be the sole presentation of psoriasis in 2.3% of children 59. 
 
A few studies have compared the clinical presentation of childhood psoriasis according to 
ethnicity, gender and age. No clear conclusions can be drawn about the effect of ethnicity 
55,79. The presentation may vary according to gender. A multicentre cross-sectional study 
from the United States found that in boys nail psoriasis was found more frequently (odds 
ratio (OR) 3.01 (CI 1.62-5.6)) and scalp psoriasis less frequently (OR) 0.40 (CI 0.19-0.84)) 
compared to girls 81. The authors suggested that this may be a result of the Kobener 
phenomenon.  
 
Age appears to be an important factor influencing presentation. Kwon et al reported that 
guttate, plaqueand generalised pustular psoriasis were significantly more common in 
children under the age of 12 years 60. Flexural involvement was found to be more common 
in pre-pubertal children (OR 2.8, p<0.05), especially boys (OR 2.5, p<0.05) 61. Kim et al found 
involvement of the face to be a more common presenting site in children compared to 
adults 84. 
 
Percentages for the frequency of initial site of presentation and subtype of psoriasis varied 
widely. Possible explanations include differences in clinic populations studied as well as the 
definition, assessment and documentation of subtypes and sites of presentation.  
 
What are the genetic and environmental factors associated with the onset of psoriasis in 
childhood? 
 
Genetic factors 
Eight studies reported genetic findings on paediatric-onset psoriasis (Table 2) 61,65,71,72,92-95. 
The studies suggest a difference in the genetics of for pre and post pubertal onset psoriasis. 
Lysell et al (2013) found endoplasmic reticulum aminopeptidase type 1 (ERAP1) was only 
associated with onset of psoriasis between the ages of 10 and 20 years 94. In 2015, Lysell et 
al found proportion of HLA-C*06 positive patients was higher amongst those with post-
pubertal onset 61. Conversely, IL22 promotor and IL12B were only associated with onset of 
psoriasis under the age of 10 years 65,95.  
 
Nanda et al found no association between psoriasis and HLA-C*06 in Kuwaiti children, unlike 
similar studies in mostly Caucasian children 72. This study highlights the need for genetic 
studies in more diverse populations. 
 
Two studies specifically looked at the genotype-phenotype correlation. HLA-C*06 was 
associated with guttate psoriasis (OR 3.4, p<0.5) and facial lesions (OR 3.8, P<0.01), after 
controlling for demographic variables 61, but HLA-C*06 negative patients were found to 
have greater nail involvement (OR 0.32 (CI 0.14-0.76)) 65. Whilst there is some data it is 
evident that further genotype-phenotype correlations in childhood psoriasis are needed.  
 
Environmental factors: Infection, emotional stress, trauma and obesity 
Trigger factors for the onset of psoriasis are reported in a large number of studies but often 
the study design employed did not allow the time relationship between exposure and the 
onset of psoriasis to be assessed. The data from these 20 studies are presented in Table 3 
18,30,34,51,52,54,57,59,65,67,70,72,76,77,79-82,84,96. Only one paper, Ozden et al, specifically investigated 
environmental risk factors for the onset of childhood psoriasis in a case control study 82.  
 
Infection was identified as a potential trigger factor in up to 43.4% of children. The most 
commonly described infection was an upper respiratory tract infection. Two studies 
specifically reported streptococcal infection, occurring in 22.1% to 21.3% of children 30,81, 
and Nyfors et al found elevated antistreptococcal titres in 60% of children with psoriasis 77. 
Other types of infection identified as triggers were urinary tract infections, chicken pox and 
otitis media.  
 
Stress was identified as a potential trigger factor in 1% to 66.7% of children; this was mostly 
defined as emotional or psychological stress. Ozden et al found that a stressful life event 
was a risk factor for the onset of psoriasis (OR 2.94 (CI = 2.28-3.79)) 82. 
 
A history of trauma of all types was identified as a potential trigger factor in 1 to 11.5% of 
children. Koebnerisation was reported in 20.4% to 49.6% of children but further details 
about the timing in relation to disease onset were not always reported. 
 
Obesity may be an important risk factor for the onset of psoriasis. Ozden et al found that 
that a BMI >26kg/m2 was a risk factor for psoriasis in children ((OR of 2.52 (CI = 1.42-4.49)). 
A small retrospective cohort study found diagnosis of obesity or overweight preceded 
psoriasis in 93% of children 51.  Boccardi et al reported that the OR of being obese at first 
diagnosis of psoriasis was 2.55 (CI 1.31-4.96) 54. 
 
There is a need for studies to differentiate between risk factors for disease onset and 
aggravating factors for a disease flare. Details on identification and measurement of 
potential risk factors are often minimal, making evaluation of their clinical relevance 
difficult.  
 
 
 
 
What other conditions are associated with psoriasis in children? 
 
Studies investigating diseases associated with psoriasis varied in methodology and only 
three used a study design which allowed a causal relationship to be assessed. Eighteen 
studies reported data on associated diseases (Table 4) 11,13,20,24,61,69,80,91,97-106. Nineteen 
studies reported data on juvenile psoriatic arthritis and these papers are summarised below. 
 
Eleven studies have provided data on cardiovascular disease and hypertension. Childhood 
psoriasis may increase the risk of hypertension. In two retrospective cohort studies 
hypertension was found in 1% (p=0.0005) 101 and up to 0.5% of children following a 
diagnosis of psoriasis 100. A significant association with cardiovascular disease has not been 
shown. 
 
Obesity data are presented in eleven studies, many of which support a significant 
association between psoriasis and obesity. Kimball et al reported the prevalence following a 
diagnosis of obesity amongst patients under 18 years to be 1.8% (p=0.0007) 101, much lower 
than large cross-sectional studies such as Mahe et al 2015, Lysell et al and Paller et al, 10% 
(p=0.001), 15% and 20.2% (p<0.001) respectively 61,91,103. This may imply that obesity was 
coexistent at the onset of psoriasis, as reported by Becker et al 51.  
 
Twelve studies have presented data on metabolic disease. A retrospective cohort found 
following a diagnosis of psoriasis, children were at higher risk of diabetes and 
hyperlipidaemia 101. 
 
Four studies reported findings on psychological disorders and childhood psoriasis. Kimball et 
al investigated the onset of a psychological disorder following a diagnosis of psoriasis. The 
hazards ratio was significantly raised for any psychiatric disorder (HR 1.25(CI1.11-1.4)) 101.  
 
Juvenile Psoriatic arthritis 
Nineteen studies reported data on juvenile psoriatic arthritis in a paediatric psoriasis 
population 13,32,51,52,56-59,61,64,79-82,90,91,99,101,103. In a predominantly plaque or guttate psoriasis 
population, the prevalence of psoriatic arthritis was reported between 0.7% and 10.5%. In a 
case series of seven children with pustular psoriasis, two children were found to have 
psoriatic arthritis 57. The highest percentage (10.5%) was reported by Mercy et al, which 
was; a secondary/hospital multicentre study of children with plaque psoriasis aged 5 to 17 
years 81. 
 
What are the long-term outcomes for patients with child-onset psoriasis? 
 
Twenty-two studies provided data on the natural history and long-term outcomes of child-
onset psoriasis 2,3,34,50,52,56,68,69,73,76,77,83,86-89,107-112. Ten studies reported the percentage of 
adult psoriasis patients with child-onset disease; this was found to be between 12% and 
37.1% and much lower in a study solely on genital psoriasis (5%) 110. Four studies, either 
prospectively or retrospectively, followed up infants with psoriasiform napkin disease. In a 
small cohort of nine infants, seven had recurrent psoriasis 86, whereas the proportion in 
larger studies was much lower. Neville et al found that 16.9% of 71 infants with psoriasiform 
changes developed psoriasis in childhood 89, while Andersen et al only found that this 
occurred in only 3% 50. Continuous disease throughout childhood occurs in 5.4% to 56% 
52,77,83. 
 
In terms of long-term severity of child-onset disease, Lombolt reported that 35% of 
psoriatics with child-onset disease had significant disease and flares compared with 18% of 
those with onset over the age of 20 years 2. Two studies investigated quality of life in child-
onset psoriasis. De Jager et al found that intra-patient rating of quality of life was lower in 
childhood compared to adulthood in those with persistent disease 68. Kim et al found 
compared lifetime quality of life scores were lower for those with child-onset disease 
compared to adult-onset 111. This supports the theory of a cumulative life-course 
impairment described by Warren et al 109. 
 
Cohort studies on the natural history of child-onset psoriasis have to date focused on napkin 
psoriasis and therefore information on the outcomes even within childhood is extremely 
limited. Data on child-onset psoriasis is often obtained from adults with persistent disease, 
which introduces recall bias and misses those whose psoriasis resolves. 
 
Discussion 
 
Summary of findings 
Over the past 25 years in the field of childhood psoriasis epidemiology there has been a 
dramatic increase in the volume of published studies; the majority of which have been case 
series and cross section studies concentrated in Europe, Asia and North America. 
 
The prevalence of childhood psoriasis was found to be higher in European countries, older 
children and females. Up to 48.8% of children had psoriasis in a first degree relative. The 
most frequent subtype was plaque psoriasis and initial site of presentation is most 
commonly scalp, limbs and trunk. Specific genetic differences have been found between the 
child-onset and adult-onset populations. Case-control studies and cohort studies 
investigating risk factors for psoriasis onset, comorbidities and long-term health outcomes 
were extremely limited. 
 
Strengths and limitations 
This scoping review is the first paper to search and map epidemiological data on child-onset 
psoriasis. The search strategy was designed to be extensive and the protocol planned to 
reduce selection bias in the stages of screening and eligibility assessment of papers. We 
recognise that a limitation of the review is the absence of structured critical appraisal of 
individual studies.  
 
Research gaps 
This scoping review has demonstrated gaps in our evidence base about childhood psoriasis 
relating to all four of the questions this review set out to address. Although over 100 studies 
contain epidemiological data, the choice of study design and heterogeneity in methodology 
limit the validity and generalisability of the information, consistency of the results and 
comparability of the studies.  
 
Population-based incidence and prevalence studies are needed, investigating the impact of 
variables such as geographic location and socioeconomic groups. Specifically designed 
studies are needed to investigate the impact of age, puberty, gender and ethnicity on the 
genotype-phenotype of psoriasis. We would suggest that there is a need for case control 
studies to investigate potential risk factors for the onset of disease. Retrospective, and 
ideally prospective, cohort studies would provide important data on the development of 
associated diseases and long-term outcomes. 
 
Standardisation is required to reduce variation in methodology. A clear definition of 
psoriasis and the subtypes would ensure patients included in studies are confirmed to have 
the same disease and subtype frequencies could be accurately recorded. Clear definition of 
potential risk factor and associated diseases as well as standardisation of parameters 
measured would help the generalisability of the findings and allow a meta-analysis of 
results.  
 
Conclusions 
Energy and focus now needs to be directed to well-designed studies with standardised 
definitions and methodology.  These studies will provide precise and consistent information 
about the frequency and clinical presentation, risk factors, associated diseases and long-
term outcomes in child-onset psoriasis.  
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